During his verbalize titled "From University Collaboration to $100M Acquisition: H5N1 Tearful Tale of BioDesign," Ackermann volition explicate how acquisition yesteryear a global pharmaceutical giant is helping him attain his destination of reaching equally many patients equally possible as well as volition highlight his journeying equally a BioDesign Fellow at the Stanford Byers Center for BioDesign. Ackermann volition hash out why big tech companies accept however to disrupt healthcare as well as how that translates into big opportunities for entrepreneurs, students, as well as faculty interested inward startups.
The seminar is scheduled for Thursday, Oct. 26 from 6:00- 7:15 p.m. inward Fung Auditorium inward the Powell-Focht Bioengineering Hall. Register to attend at http://bluelincsd.com/.